EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Differences in the concanavalin induced re distribution and agglutination patterns of epstein barr virus genome free and epstein barr virus carrying human lymphoma lines


Experimental Cell Research 108(1): 185-190
Differences in the concanavalin induced re distribution and agglutination patterns of epstein barr virus genome free and epstein barr virus carrying human lymphoma lines
EBV[Epstein-Barr virus]-carrying human lymphoid lines showed a reduced redistribution of concanavalin A (ConA) receptors after ligand contact, compared with EBV negative lines. ConA agglutinability showed the opposite pattern, high in EBV-positive, low in EBV-negative lines. The same differences were also found in a comparison between 2 EBV-negative lines and their in vitro EBV-converted, viral genome-carrying sublines, suggesting that the viral genome is directly responsible.


Accession: 005151168



Related references

Further studies on the differences in serum dependence in epstein barr virus negative lymphoma lines and their in vitro epstein barr virus converted virus genome carrying sublines. European Journal of Cancer 13(11): 1269-1276, 1977

Establishment of epstein barr virus nuclear antigen expressing cell lines by infection of epstein barr virus genome negative human lymphoma cells with different epstein barr virus strains. International Journal Of Cancer: 161-166, 1976

Relationship between the amounts of epstein barr virus dna and epstein barr virus nuclear antigen per cell clonability and tumorigenicity in 2 epstein barr virus negative lymphoma lines and their epstein barr virus converted sublines. International Journal of Cancer 31(2): 163-170, 1983

Hexose transport in epstein barr virus negative lymphoma lines and their epstein barr converted virus genome carrying sublines. Blut 43(5): 297-306, 1981

Molecular size variation of epstein barr virus induced nuclear antigen is determined by the epstein barr viral genome studies on sublines of epstein barr virus negative lymphomas converted with different epstein barr virus substrains and on somatic hybrids. Intervirology 22(2): 85-96, 1984

Epstein barr virus induced increase in the concanavalin a receptor density of established epstein barr virus negative lymphoma lines in vitro. Experimental Hematology (Charlottesville) 8(10): 1173-1182, 1980

Difference in antibody induced re distribution of membrane immuno globulin m in epstein barr virus genome free and epstein barr virus positive human lymphoid cells. Experimental Cell Research 99(1): 175-178, 1976

An epstein barr virus genome negative cell line established from an american burkitts lymphoma receptor characteristics epstein barr virus infectibility and permanent conversion into epstein barr virus positive sublines by in vitro infection. Intervirology 5(6): 319-334, 1975

Inducibility of the epstein barr virus cycle and surface marker properties of epstein barr virus negative lymphoma lines and their in vitro epstein barr virus converted sublines. International Journal of Cancer 18(5): 639-652, 1976

Poly ploidization of epstein barr virus carrying lymphoma lines decreases the inducibility of epstein barr virus determined early antigen following p 3hr 1 virus super infection or iododeoxy uridine treatment. Intervirology 10(2): 94-101, 1978